Litigation
GenPharm International, Inc. v. Abgenix, Inc.
settledAuto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Terminated
- 1997-03-27
Patents at issue (3)
Plaintiffs (1)
Defendants (1)
Summary
GenPharm International filed an infringement counter-suit against Abgenix, Inc. in early 1997, reportedly asserting US 5,545,806 and US 5,569,825. The litigation was settled on March 27, 1997 through a comprehensive cross-license among Cell Genesys, Abgenix, Xenotech L.P., Japan Tobacco Inc., and GenPharm, and all litigation was dismissed. US 5,625,126 was not named in the contemporaneous account and issued after the settlement.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).